Opinion|Videos|August 5, 2024

Financial Challenges of BTK Inhibitor Therapy in CLL: Impact on Access and Utilization

Experts discuss financial challenges of BTK inhibitor therapy.

Video content above is prompted by the following question(s):

  1. What are the financial burdens of BTK inhibitor therapy? How does the cost of BTK inhibitors impact access and utilization for patients with CLL?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo